The HALT Biomarker Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The HALT Biomarker Study — Stella

Recruiting

Back to Aortic Stenosis trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

Massachusetts General Hospital, Boston, Massachusetts

Minneapolis Heart Institute, Minneapolis, Minnesota

Catholic Medical Center, Manchester, New Hampshire

Key details

Phase

Early testing

Sponsor

Massachusetts General Hospital

Collaborators

Medtronic, Catholic Medical Center

Enrollment target

~300 participants

Started

June 2020

Primary completion

June 2030

Age range

65 Years and older

Last updated November 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov